# PDX Pharmaceuticals, Inc. — Form D

PDX Pharmaceuticals, Inc. of PORTLAND, OR, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-27. The offering totals $4.0M, of which $1.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2019-11-27
- Form: D
- Accession: 0001795304-19-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.6M
- Remaining: $2.5M
- Investors: 2
- Date of first sale: 2019-11-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-354434

## Issuer

- Name: PDX Pharmaceuticals, Inc.
- CIK: 0001795304
- Entity type: Corporation
- Jurisdiction: OREGON
- Address: 3303 SW BOND AVENUE, CH13B, PORTLAND, OR, 97239
- Phone: 503-418-9306

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Joe Gray | Director | PORTLAND, OR |
| Angela Hult | Director | PORTLAND, OR |
| Wassana Yantasee | Director | PORTLAND, OR |
| Worapol Ngamcherdtrakul | Executive Officer | PORTLAND, OR |
| Wassana Yantasee | Executive Officer | PORTLAND, OR |

## More

- [CIK 1795304 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1795304&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001795304-19-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.